Top View
- Cephalosporins: a Focus on Side Chains and -Lactam Cross-Reactivity
- Shionogi Briefing Document
- Ceftibuten Dihydrate Capsule CEDAX - Ceftibuten Dihydrate Suspension Pernix Therapeutics, LLC
- Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
- K. Pneumoniae Isolates by Geographic Region 50 90 USA EUR APAC LATAM All ESBL-Producing E
- Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium Difficile Infection Comparative Effectiveness Review Number 31
- Review of the Pharmacology, Pharmacokinetics, and Clinical Use
- ESCMID, WAAAR, React, ISC, BSAC
- 2019 Antibacterial Agents in Clinical Development
- Different Antibiotic Treatments for Group a Streptococcal Pharyngitis (Review) Van Driel ML, De Sutter AIM, Keber N, Habraken H, Christiaens T
- Cephalosporins:A Review
- Antimicrobial Use Guidelines
- 203195Orig1s000
- Synergistic Antibiotic Effect of Cefuroxime & Clavulanic Acid
- Oral Antibiotic Exposure and Kidney Stone Disease
- Pyelonephritis (Acute): Antimicrobial Prescribing Guideline Evidence Review
- (12) Patent Application Publication (10) Pub. No.: US 2011/0152311 A1 Dedhiya Et Al
- Cephalosporins*
- Changes in Fecal Flora and Comparative Multiple-Dose Pharmacokinetics of Ceftibuten, Cefpodoxime Proxetil and Amoxycillin/Clavulanate
- P1181 Selection of Ceftibuten As the Partner Antibiotic for the Oral Beta
- EAU Urological Infections Antibacterial Agents
- Summary of Product Characteristics
- Critically Important Antimicrobials for Human Medicine
- Therapeutic Class Review Third Generation Cephalosporins